483 SOFIE dba SOFIE Jan 2019

483 SOFIE dba SOFIE Jan 2019

Patty Kaewussdangkul FDA$119.00 - Available Now

FDA investigators audited the SOFIE dba SOFIE - Dallas, TX, United States facility and issued inspectional observations (via FDA 483) on 15 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Jan 2019
  • Location: Dallas, United States
  • FEI: 3008486071
Add To Cart